Your browser doesn't support javascript.
loading
Emergency Heart failure Mortality Risk Grade may help to reduce heart failure admissions.
van Hattem, N E; Beeres, S L M A; Mertens, B J A; Antoni, M L; Atsma, D E; Schalij, M J; den Haan, M C.
Afiliação
  • van Hattem NE; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Beeres SLMA; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Mertens BJA; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Antoni ML; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Atsma DE; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Schalij MJ; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • den Haan MC; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. M.C.den_Haan@lumc.nl.
Neth Heart J ; 30(9): 431-435, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35277803
ABSTRACT

INTRODUCTION:

Hospital admissions for heart failure (HF) are frequent and pose a heavy burden on health care resources. Currently, the decision to hospitalise is based on clinical judgement rather than on prognostic risk stratification. The Emergency Heart failure Mortality Risk Grade (EHMRG) was recently developed to identify high-risk HF patients in the emergency department (ED).

OBJECTIVE:

To assess the ability of the EHMRG to predict 30-day mortality in Dutch HF patients visiting the ED and to evaluate whether the EHMRG could help to reduce the number of hospital admissions for decompensated HF.

METHODS:

Patients visiting the ED for decompensated HF were included. The decision to hospitalise or discharge was based on clinical judgement. The EHMRG was calculated retrospectively. Based on their EHMRG, patients were stratified as very low risk, low risk, intermediate risk, high risk and very high risk.

RESULTS:

In 227 patients (age 73 ± 12 years, 69% male) 30-day mortality was 11%. Mortality differed significantly among the EHMRG risk groups at 7­day (p = 0.012) and 30-day follow-up (p < 0.01). Based on clinical judgement, 76% of patients were hospitalised. If decision-making had been based on EHMRG, the hospitalisation rate could have been reduced to 66% (p < 0.01), particularly by reducing hospitalisations in patients at low risk of death. Mortality in discharged patients, whether the decision was based on EHMRG or clinical judgement, was 0%.

CONCLUSION:

The EHMRG accurately differentiates between high- and low-risk decompensated HF patients visiting the ED, making it a promising tool to safely reduce the number of HF admissions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article